Also known as آسٹیوپوروسس مینجمنٹ
General Physician
MBBS, MCPS (Family Medicine)
Rheumatologist
MBBS, MCPS, MRCGP, DTTMH, MASTMH, MRACGP, Family Medicine Residency Training Certification
Rheumatologist
MBBS, MCPS, MRCGP, DTTMH, MASTMH, MRACGP, Family Medicine Residency Training Certification
Internal Medicine Specialist
MBBS, MCPS (Family Medicine)
Diabetologist
MBBS, Dip in Diabetics
Diabetologist
M.B.B.S, MRCP (UK), MRCP (London), Specialty Certificate in Endocrinology and Diabetes
Diabetologist
M.B.B.S, MRCP (UK), MRCP (London), Specialty Certificate in Endocrinology and Diabetes
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Endocrinology Diabetes and Metabolism)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Endocrinology Diabetes and Metabolism)
Endocrinologist
M.B.B.S, Dip. in Diabetology, MACE (USA), FRSPH (UK)
Diabetologist
MBBS, FCPS, MCPS, Fellowship in Diabetes and Endocrinology, MPH
Diabetologist
MBBS, FCPS, MCPS, Fellowship in Diabetes and Endocrinology, MPH
Diabetologist
MBBS, Diploma in Diabetes from BIDE
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures